|1.||Gurtsevitch, Vladimir: 2 articles (02/2014 - 03/2005)|
|2.||Park, Chaehwa: 2 articles (09/2013 - 12/2010)|
|3.||Kim, Joo Hyun: 2 articles (09/2013 - 12/2010)|
|4.||Kim, Won Seog: 2 articles (09/2013 - 12/2010)|
|5.||Endo, Kazuhira: 2 articles (03/2013 - 11/2011)|
|6.||Yoshizaki, Tomokazu: 2 articles (03/2013 - 11/2011)|
|7.||Pagano, Joseph S: 2 articles (03/2013 - 11/2011)|
|8.||Chen, Xiao-Yi: 2 articles (08/2008 - 02/2008)|
|9.||Lu, John Jenn-Yenn: 2 articles (01/2007 - 06/2002)|
|10.||Zhao, Sha: 2 articles (11/2005 - 05/2005)|
11/01/2011 - "Epstein-Barr virus latent membrane protein 1 induces cancer stem/progenitor-like cells in nasopharyngeal epithelial cell lines."
12/01/2010 - "Epstein-Barr virus latent membrane protein 1 increases chemo-resistance of cancer cells via cytoplasmic sequestration of Pim-1."
12/26/2008 - "Tumor-derived variants of Epstein-Barr virus latent membrane protein 1 induce sustained Erk activation and c-Fos."
05/01/2000 - "Epstein-Barr virus latent membrane protein 1 (EBV-LMP1) and tumor proliferation rate as predictive factors of nasopharyngeal cancer (NPC) radiation response."
02/01/2014 - "Epstein-barr virus latent membrane protein 1 polymorphism in nasopharyngeal carcinoma and other oral cavity tumors in Russia."
|2.||Neoplasm Metastasis (Metastasis)
09/01/2008 - "Epstein-Barr virus latent membrane protein 1 (LMP1) has oncogenic and metastasis-promoting activity. "
02/01/2007 - "The C-terminal activation region 2 (CTAR2) of Epstein-Barr virus latent membrane protein 1 is the major site that correlates with metastasis-related signaling pathway. "
08/01/2008 - "[Effects of Epstein-Barr virus latent membrane protein 1 on metastasis of human nasopharyngeal carcinoma cell lines]."
02/01/2008 - "[Impact of up-regulating Ezrin expression by Epstein-Barr virus latent membrane protein 1 on metastasis ability of nasopharyngeal carcinoma cells]."
02/01/2008 - "Ezrin, a cytoskeleton-related protein, contributes to the invasion and metastasis of tumors; our previous study had also shown that Epstein-Barr virus latent membrane protein 1 (EBV-LMP1) can promote the metastasis of nasopharyngeal carcinoma (NPC) cells. "
|3.||Lymphoproliferative Disorders (Lymphoproliferative Disorder)
03/01/1996 - "In situ hybridization studies performed on lymph node tissue revealed expression of Epstein-Barr virus-encoded RNA 1 transcripts, and immunohistochemical studies revealed expression of Epstein-Barr virus latent membrane protein 1. These ancillary studies confirmed the similarity to post-transplantation lymphoproliferative disorder. "
12/01/2002 - "High frequency of a 30-bp deletion of Epstein-Barr virus latent membrane protein 1 gene in primary HIV non-Hodgkin's brain lymphomas."
03/10/2001 - "[Expression of Epstein-Barr virus membrane antigen induces lymphoma in transgenic mice]."
11/01/1997 - "The Epstein-Barr virus latent membrane protein 1 (LMP-1) is essential for virus-induced B cell immortalization and can protect B lymphoma cell lines from apoptosis signals in vitro via induction of cellular Bcl-2 expression. "
06/01/1996 - "Immunostaining for Epstein-Barr virus (latent membrane protein-1) and Epstein-Barr virus-encoded RNA-1 in situ hybridization did not demonstrate an association of these lymphoma with Epstein-Barr virus infection. "
01/01/2002 - "The Epstein-Barr virus latent membrane protein 1 putative Janus kinase 3 (JAK3) binding domain does not mediate JAK3 association or activation in B-lymphoma or lymphoblastoid cell lines."
|5.||Hodgkin Disease (Hodgkin's Disease)
04/01/2007 - "The relationships between Epstein-Barr virus latent membrane protein 1 and regulatory T cells in Hodgkin's lymphoma."
12/01/1997 - "Deletion of Epstein-Barr virus latent membrane protein 1 gene in United States and Brazilian Hodgkin's disease and reactive lymphoid tissue: high frequency of a 30-bp deletion."
11/01/2000 - "Epstein-Barr virus-latent membrane protein 1 expression has a favorable influence in the outcome of patients with Hodgkin's Disease treated with chemotherapy."
09/15/1997 - "Adverse clinical outcome in Hodgkin's disease is associated with loss of retinoblastoma protein expression, high Ki67 proliferation index, and absence of Epstein-Barr virus-latent membrane protein 1 expression."
12/01/2010 - "Both classical Hodgkin lymphoma and plasmablastic lymphoma were positive for Epstein-Barr virus-encoded RNA, whereas classical Hodgkin lymphoma was also positive for Epstein-Barr virus- latent membrane protein 1, suggesting a different viral latency. "
|2.||Epstein-Barr virus encoded RNA 1
|4.||RNA (Ribonucleic Acid)
|6.||Janus Kinase 3
|7.||Mitogen-Activated Protein Kinase 11
|8.||Matrix Metalloproteinase 9 (Gelatinase B)
|9.||Interleukin-10 (Interleukin 10)
|1.||Transplantation (Transplant Recipients)
|3.||Drug Therapy (Chemotherapy)